Skip to main content
. 2009 Jan;16(1):16–26. doi: 10.3747/co.v16i1.361

FIGURE 4.

FIGURE 4

Overall survival by severity of skin rash in patients with third-line metastatic colorectal cancer receiving panitumumab. (From Van Cutsem et al., 2007 9.)